201
|
Pengo N, Agrotis A, Prak K, Jones J, Ketteler R. A reversible phospho-switch mediated by ULK1 regulates the activity of autophagy protease ATG4B. Nat Commun 2017; 8:294. [PMID: 28821708 PMCID: PMC5562857 DOI: 10.1038/s41467-017-00303-2] [Citation(s) in RCA: 97] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2016] [Accepted: 06/20/2017] [Indexed: 12/26/2022] Open
Abstract
Upon induction of autophagy, the ubiquitin-like protein LC3 is conjugated to phosphatidylethanolamine (PE) on the inner and outer membrane of autophagosomes to allow cargo selection and autophagosome formation. LC3 undergoes two processing steps, the proteolytic cleavage of pro-LC3 and the de-lipidation of LC3-PE from autophagosomes, both executed by the same cysteine protease ATG4. How ATG4 activity is regulated to co-ordinate these events is currently unknown. Here we find that ULK1, a protein kinase activated at the autophagosome formation site, phosphorylates human ATG4B on serine 316. Phosphorylation at this residue results in inhibition of its catalytic activity in vitro and in vivo. On the other hand, phosphatase PP2A-PP2R3B can remove this inhibitory phosphorylation. We propose that the opposing activities of ULK1-mediated phosphorylation and PP2A-mediated dephosphorylation provide a phospho-switch that regulates the cellular activity of ATG4B to control LC3 processing.Upon autophagy induction, LC3 is cleaved by the protease ATG4 and conjugated to the autophagosomal membrane; however, its removal is mediated by the same protease. Here the authors show that ULK1-mediated phosphorylation and PP2A-mediated dephosphorylation of ATG4 regulates its cellular activity to control LC3 processing.
Collapse
Affiliation(s)
- N Pengo
- MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK
| | - A Agrotis
- MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK
| | - K Prak
- MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK
| | - J Jones
- MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK
| | - R Ketteler
- MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London, WC1E 6BT, UK.
| |
Collapse
|
202
|
Whitla L, Jones J, Barrett MJ, O'Donnell SM, Walsh S, Blackburn C. Atresia Hymenalis with Haematometrocolpos: A Benefit of Teaching a Case Series and Review of the Literature. Ir Med J 2017; 110:623. [PMID: 29169005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
We present four cases of atresia hymenalis with resultant haematometrocolpos diagnosed in quick succession in the emergency department with a literature review.
Collapse
Affiliation(s)
- L Whitla
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
| | - J Jones
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
| | - M J Barrett
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
- Paediatric Emergency Research Unit, National Children's Research Centre
| | - S M O'Donnell
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
- Paediatric Emergency Research Unit, National Children's Research Centre
| | - S Walsh
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
- Paediatric Emergency Research Unit, National Children's Research Centre
| | - C Blackburn
- Department of Emergency Medicine, Our Lady'sChildren's Hospital Crumlin
- Paediatric Emergency Research Unit, National Children's Research Centre
| |
Collapse
|
203
|
Albert S, King J, Jones J, Park Y, Newman A. USING A STATE AGING SERVICES INFRASTRUCTURE TO PROMOTE PREVENTION GUIDELINES. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.3000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- S.M. Albert
- Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - J. King
- Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - J. Jones
- Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Y. Park
- Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - A. Newman
- Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
| |
Collapse
|
204
|
Burke R, Lawrence E, Ladebue A, Ayele R, Reither J, Jones J, Cumbler E, Allyn R. MAKING BETTER DECISIONS ABOUT POST-ACUTE CARE: KEY STAKEHOLDER PERSPECTIVES. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- R.E. Burke
- Research and Hospital Medicine Sections, Denver VA Medical Center, Denver, Colorado,
| | - E. Lawrence
- Research and Hospital Medicine Sections, Denver VA Medical Center, Denver, Colorado,
| | - A. Ladebue
- Research and Hospital Medicine Sections, Denver VA Medical Center, Denver, Colorado,
| | - R. Ayele
- Research and Hospital Medicine Sections, Denver VA Medical Center, Denver, Colorado,
| | - J. Reither
- Research and Hospital Medicine Sections, Denver VA Medical Center, Denver, Colorado,
| | - J. Jones
- University of Colorado College of Nursing, Aurora, Colorado,
| | - E. Cumbler
- University of Colorado School of Medicine, Aurora, Colorado,
| | - R. Allyn
- Denver Health and Hospital Authority, Denver, Colorado
| |
Collapse
|
205
|
McEwen S, Dunphy C, Norman Rios J, Davis A, Jones J, Lam A, Poon I, Martino R, Ringash J. Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer. ACTA ACUST UNITED AC 2017; 24:153-160. [PMID: 28680274 DOI: 10.3747/co.24.3529] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND In contrast with other major chronic conditions such as heart disease and stroke, cancer care does not routinely integrate evidence-based rehabilitation services within the standard continuum. The objectives of the present project were to develop a rehabilitation planning consultation (rpc) for survivors of head-and-neck (hn) cancer, to test its feasibility, and to make refinements. METHODS Using intervention mapping, the rpc-alpha was developed by examining potential theoretical methods and practical applications relative to the program objectives. During feasibility testing, a single case series was conducted with survivors of hn cancer who had completed their cancer treatment within the preceding 11 months; iterative refinements were made after each case. RESULTS The rpc-alpha was led by a rehabilitation professional and was based on self-management principles. The initial consultation included instruction in a global cognitive strategy, goal-setting, introduction to available resources, action planning, and coping planning. A follow-up consultation was conducted a few weeks later. Of 9 participants recruited, 5 completed post-intervention assessments. Participants reported that the rpc helped them to make rehabilitation plans. CONCLUSIONS The rpc was feasible to use and satisfactory to a small group of hn cancer survivors. A pilot test of the refined version is in process.
Collapse
Affiliation(s)
- S McEwen
- Sunnybrook Research Institute, St. John's Rehab Research Program, Toronto.,University of Toronto, Toronto
| | - C Dunphy
- University Health Network, Princess Margaret Cancer Centre, Toronto
| | - J Norman Rios
- Sunnybrook Research Institute, St. John's Rehab Research Program, Toronto
| | - A Davis
- University of Toronto, Toronto.,University Health Network, Toronto Western Research Institute, Toronto
| | - J Jones
- University of Toronto, Toronto.,University Health Network, Princess Margaret Cancer Centre, Toronto
| | - A Lam
- University Health Network, Princess Margaret Cancer Centre, Toronto.,The University of Western Ontario, London; and
| | - I Poon
- University of Toronto, Toronto.,Odette Cancer Centre, Sunnybrook Hospital, Toronto, ON
| | | | - J Ringash
- University of Toronto, Toronto.,University Health Network, Princess Margaret Cancer Centre, Toronto
| |
Collapse
|
206
|
Montillo M, Byrd J, Hillmen P, O'Brien S, Barrientos J, Reddy N, Coutre S, Tam C, Mulligan S, Jaeger U, Barr P, Furman R, Kipps T, Thornton P, Moreno C, Pagel J, Burger J, Jones J, Dai S, Vezan R, James D, Brown J. LONG-TERM EFFICACY AND SAFETY IN THE RESONATE STUDY: IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH UP TO FOUR YEARS FOLLOW-UP. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_98] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Montillo
- Department of Haematology & Oncology; Niguarda Cancer Center, Niguarda Hospital; Milan Italy
| | - J.C. Byrd
- Division of Hematology, Department of Internal Medicine; The Ohio State University Comprehensive Cancer Center; Columbus USA
| | - P. Hillmen
- Department of Haematology; The Leeds Teaching Hospitals, St. James Institute of Oncology; Leeds UK
| | - S. O'Brien
- Chao Family Comprehensive Cancer Center; University of California Irvine; Orange USA
| | - J.C. Barrientos
- Division of Hematology and Medical Oncology; Department of Medicine, Hofstra Northwell School of Medicine; Hempstead USA
| | - N.M. Reddy
- Hematology/Oncology; Vanderbilt-Ingram Cancer Center; Nashville USA
| | - S. Coutre
- Division of Hematology, Stanford Cancer Center; Stanford University School of Medicine; Stanford USA
| | - C.S. Tam
- Department of Haematology, Peter MacCallum Cancer Centre and St. Vincent's Hospital; Melbourne Australia
| | - S.P. Mulligan
- Hematology; Royal North Shore Hospital, St. Leonards; Australia
| | - U. Jaeger
- Division of Hematology and Hemostaseology; Medical University of Vienna; Wien Austria
| | - P.M. Barr
- James P. Wilmot Cancer Center
- Department of Medicine, Hematology/Oncology; University of Rochester Medical Center; Rochester USA
| | - R.R. Furman
- Division of Hematology and Medical Oncology, Weill Cornell Medical College; New York USA
| | - T.J. Kipps
- Moores Cancer Center; University of California San Diego; La Jolla USA
| | - P. Thornton
- Department of Haematology; Beaumont Hospital; Dublin Republic of Ireland
| | - C. Moreno
- Hematology Department; Hospital de la Santa Creu Sant Pau; Barcelona Spain
| | - J.M. Pagel
- Hematologic Malignancies Program; Swedish Cancer Institute; Seattle USA
| | - J.A. Burger
- Department of Leukemia; University of Texas MD Anderson Cancer Center; Houston USA
| | - J. Jones
- Division of Hematology, Department of Internal Medicine; The Ohio State University Comprehensive Cancer Center; Columbus USA
| | - S. Dai
- Biostatistics; Pharmacyclics LLC, an AbbVie Company; Sunnyvale USA
| | - R. Vezan
- Clinical Research; Pharmacyclics LLC, an Abbvie Company; Sunnyvale USA
| | - D.F. James
- Clinical Research; Pharmacyclics LLC, an Abbvie Company; Sunnyvale USA
| | - J.R. Brown
- Division of Hematologic Malignancies; CLL Center, Dana-Farber Cancer Institute; Boston USA
| |
Collapse
|
207
|
Payne-Rogers C, Kenyon M, Jones J. 0041 PREDICTING TRAIT-LIKE VARIABILITY IN THE COEFFICIENTS OF THE TWO PROCESS MODEL OF PERFORMANCE. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
208
|
Johnston L, Jones J, Davison C, Lkhagvasuren O, Janes C. Produce and Protect? Extractive Industry Tensions in a Sustainable
Development Agenda. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
209
|
Breathett K, Liu W, Allen L, Daugherty S, Blair I, Jones J, Grunwald G, Moss M, Kiser T, Burnham E, Vandivier R, Clark B, Lewis E, Mazimba S, Ho P, Peterson P. Racial Differences in Receipt of Care by a Cardiologist During a Critical Heart Failure Admission. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
210
|
Faust C, Jones J, Huennekens J, Field RW. Experimental studies of the NaCs 12(0 +) [7 1Σ +] state: Spin-orbit and non-adiabatic interactions and quantum interference in the 12(0 +) [7 1Σ +] and 11(0 +) [5 3Π 0] emission spectra. J Chem Phys 2017; 146:104302. [PMID: 28298109 DOI: 10.1063/1.4976630] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
We present results from experimental studies of the 11(0+) and 12(0+) electronic states of the NaCs molecule. An optical-optical double resonance method is used to obtain Doppler-free excitation spectra. Selected data from the 11(0+) and 12(0+) high-lying electronic states are used to obtain Rydberg-Klein-Rees and Inverse Perturbation Approach potential energy curves. Interactions between these two electronic states are evident in the patterns observed in the bound-bound and bound-free fluorescence spectra. A model, based on two separate interaction mechanisms, is presented to describe how the wavefunctions of the two states mix. The electronic parts of the wavefunctions interact via spin-orbit coupling, while the individual rotation-vibration levels interact via a second mechanism, which is likely to be non-adiabatic coupling. A modified version of the BCONT program was used to simulate resolved fluorescence from both upper states. Parameters of the model that describe the two interaction mechanisms were varied until simulations were able to adequately reproduce experimental spectra.
Collapse
Affiliation(s)
- C Faust
- Department of Physics, Lehigh University, 16 Memorial Drive East, Bethlehem, Pennsylvania 18015, USA
| | - J Jones
- Department of Physics, Lehigh University, 16 Memorial Drive East, Bethlehem, Pennsylvania 18015, USA
| | - J Huennekens
- Department of Physics, Lehigh University, 16 Memorial Drive East, Bethlehem, Pennsylvania 18015, USADepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R W Field
- Department of Physics, Lehigh University, 16 Memorial Drive East, Bethlehem, Pennsylvania 18015, USADepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| |
Collapse
|
211
|
Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, Burns E, Trock S, Zhou S, Katz JM, Jernigan DB. Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017. MMWR Morb Mortal Wkly Rep 2017; 66:254-255. [PMID: 28278147 PMCID: PMC5687196 DOI: 10.15585/mmwr.mm6609e2] [Citation(s) in RCA: 74] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
212
|
Connolly SB, Kotseva K, Jennings C, Atrey A, Jones J, Brown A, Bassett P, Wood DA. Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme. Heart 2017; 103:840-847. [PMID: 28255098 PMCID: PMC5566096 DOI: 10.1136/heartjnl-2016-310477] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Revised: 12/15/2016] [Accepted: 12/15/2016] [Indexed: 11/05/2022] Open
Abstract
Background National guidance for England recommends that cardiovascular disease (CVD) should be managed as a family of diseases in the community. Here, we describe the results of such an approach. Methods Patients with established CVD or who were at high multifactorial risk (HRI) underwent a 12-week community-based nurse-led prevention programme (MyAction) that included lifestyle and risk factor management, prescription of medication and weekly exercise and education sessions. Results Over a 6-year period, 3232 patients attended an initial assessment; 63% were male, and 48% belonged to black and minority ethnic groups. 56% attended an end-of-programme assessment, and 33% attended a one year assessment. By the end of the programme, there was a significant reduction in smoking prevalence but only in HRI (−3.7%, p<0.001). Mediterranean diet score increased in both CVD (+1.2, p<0.001) and HRI (+1.5; p<0.001), as did fitness levels (CVD +0.8 estimated Mets maximum, p<0.001, HRI +0.9 estimated Mets maximum, p<0.001) and the proportions achieving their physical activity targets (CVD +40%, p<0.001, HRI +37%, p<0.001). There were significant increases in proportions achieving their blood pressure (CVD +15.4%, p<0.001, HRI +25%, p<0.001 and low-density lipoprotein cholesterol targets (CVD +6%, p=0.004, HRI +23%, p<0.001). Statins and antihypertensive medications significantly increased in HRI. Significant improvements in depression scores and quality-of-life measures were also seen. The majority of improvements were maintained at 1 year. Conclusion These results demonstrate that an integrated vascular prevention programme is feasible in practice and reduces cardiovascular risk in patients with established CVD and in those at high multifactorial risk.
Collapse
Affiliation(s)
- S B Connolly
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| | - K Kotseva
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| | - C Jennings
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| | - A Atrey
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| | - J Jones
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK.,College of Health and Life Sciences, Brunel University, London, UK
| | - A Brown
- Public Health England, Fleetbank House, London, UK
| | - P Bassett
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| | - D A Wood
- Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
| |
Collapse
|
213
|
York W, Jones J. Addressing the mental health needs of looked after children in foster care: the experiences of foster carers. J Psychiatr Ment Health Nurs 2017; 24:143-153. [PMID: 28124485 DOI: 10.1111/jpm.12362] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/07/2016] [Indexed: 11/29/2022]
Abstract
UNLABELLED WHAT IS KNOWN ON THE SUBJECT?: In the UK and internationally, the number of looked after children is increasing year on year. Mental health problems among looked after children are significantly higher than in the general population, and the uptake of mental health services for these children is low. There is a poor prognosis for children with untreated mental health problems; this is further compounded if the child is within the care system. WHAT DOES THIS PAPER ADD TO EXISTING KNOWLEDGE?: This study adds to our understanding of foster carers' experiences of the mental health needs of looked after children and demonstrates some of the challenges associated with accessing appropriate and timely mental health services. New knowledge derived from this research is that the barriers to accessing Child and Adolescent Mental Health Services (CAMHS) are not at the time of initial referral as previously reported, but later, once within the mental health system with long waiting times experienced particularly for specialist services. This study provides new insights into the experience of being a foster carer and the levels of support and resources needed that directly relate to the viability of the placement. The majority of the foster carers interviewed were from a Black and Minority Ethnic (BME) background, previously under-represented in this research area. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: A number of areas in current CAMHS provision need addressing with a focus on accessibility, consultation and support for foster carers. Waiting times need to be addressed, and improved communication with other agencies is also highlighted. CAMHS nurses are well placed to develop and deliver a comprehensive care package to foster carers, offering more tailored support to them whilst enabling the children and young people in their care to access and engage more effectively with mental health services. ABSTRACT Introduction Despite well-documented vulnerabilities to mental health problems among the increasing population of looked after children, there continues to be poor uptake and utilization of Child and Adolescent Mental Health Services (CAMHS). Aim To elicit views of foster carers regarding the mental health needs of children and adolescents in their care and their experiences of accessing mental health services. Methods A grounded theory approach and semistructured interviews with ten foster carers. Results The experience of being a foster carer was the core category, with three major themes: (1) foster carers' psychological understanding of challenging behaviour; (2) barriers to accessing CAMHS; (3) the importance of support. Discussion A key finding of this research is that barriers to accessing CAMHS were not experienced at the point of referral, but once within the mental health system. The foster carers demonstrated a proactive approach to accessing services but expressed a need for more support structures related directly to the viability of the placement. Implications for practice Mental health nurses have a pivotal role in providing a more responsive and needs-led service for this population; professional support to foster carers to include facilitating peer support; and clinical interventions for the looked after children.
Collapse
Affiliation(s)
- W York
- School of Health Sciences, City, University of London, London, UK
| | - J Jones
- Centre for Research in Primary and Community Care (CRIPACC), University of Hertfordshire, Hatfield, Hertfordshire, UK
| |
Collapse
|
214
|
Nguyen DT, Jang Y, Nguyen TD, Jones J, Shepard SS, Yang H, Gerloff N, Fabrizio T, Nguyen LV, Inui K, Yang G, Creanga A, Wang L, Mai DT, Thor S, Stevens J, To TL, Wentworth DE, Nguyen T, Pham DV, Bryant JE, Davis CT. Shifting Clade Distribution, Reassortment, and Emergence of New Subtypes of Highly Pathogenic Avian Influenza A(H5) Viruses Collected from Vietnamese Poultry from 2012 to 2015. J Virol 2017; 91:e01708-16. [PMID: 28003481 PMCID: PMC5309939 DOI: 10.1128/jvi.01708-16] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Accepted: 11/28/2016] [Indexed: 11/20/2022] Open
Abstract
Whole-genome sequences of representative highly pathogenic avian influenza A(H5) viruses from Vietnam were generated, comprising samples from poultry outbreaks and active market surveillance collected from January 2012 to August 2015. Six hemagglutinin gene clades were characterized. Clade 1.1.2 was predominant in southern Mekong provinces throughout 2012 and 2013 but gradually disappeared and was not detected after April 2014. Clade 2.3.2.1c viruses spread rapidly during 2012 and were detected in the south and center of the country. A number of clade 1.1.2 and 2.3.2.1c interclade reassortant viruses were detected with different combinations of internal genes derived from 2.3.2.1a and 2.3.2.1b viruses, indicating extensive cocirculation. Although reassortment generated genetic diversity at the genotype level, there was relatively little genetic drift within the individual gene segments, suggesting genetic stasis over recent years. Antigenically, clade 1.1.2, 2.3.2.1a, 2.3.2.1b, and 2.3.2.1c viruses remained related to earlier viruses and WHO-recommended prepandemic vaccine strains representing these clades. Clade 7.2 viruses, although detected in only low numbers, were the exception, as indicated by introduction of a genetically and antigenically diverse strain in 2013. Clade 2.3.4.4 viruses (H5N1 and H5N6) were likely introduced in April 2014 and appeared to gain dominance across northern and central regions. Antigenic analyses of clade 2.3.4.4 viruses compared to existing clade 2.3.4 candidate vaccine viruses (CVV) indicated the need for an updated vaccine virus. A/Sichuan/26221/2014 (H5N6) virus was developed, and ferret antisera generated against this virus were demonstrated to inhibit some but not all clade 2.3.4.4 viruses, suggesting consideration of alternative clade 2.3.4.4 CVVs.IMPORTANCE Highly pathogenic avian influenza (HPAI) A(H5) viruses have circulated continuously in Vietnam since 2003, resulting in hundreds of poultry outbreaks and sporadic human infections. Despite a significant reduction in the number of human infections in recent years, poultry outbreaks continue to occur and the virus continues to diversify. Vaccination of poultry has been used as a means to control the spread and impact of the virus, but due to the diversity and changing distribution of antigenically distinct viruses, the utility of vaccines in the face of mismatched circulating strains remains questionable. This study assessed the putative amino acid changes in viruses leading to antigenic variability, underscoring the complexity of vaccine selection for both veterinary and public health purposes. Given the overlapping geographic distributions of multiple, antigenically distinct clades of HPAI A(H5) viruses in Vietnam, the vaccine efficacy of bivalent poultry vaccine formulations should be tested in the future.
Collapse
Affiliation(s)
- Diep T Nguyen
- National Center for Veterinary Diagnostics, Department of Animal Health, Hanoi, Vietnam
- Department of Animal Health, Ministry of Agriculture and Rural Development of Vietnam, Hanoi, Vietnam
- Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Hanoi, Vietnam
- Center for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
| | - Yunho Jang
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Tho D Nguyen
- National Center for Veterinary Diagnostics, Department of Animal Health, Hanoi, Vietnam
| | - Joyce Jones
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Samuel S Shepard
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Hua Yang
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Nancy Gerloff
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Thomas Fabrizio
- St. Jude's Center for Excellence in Influenza Research and Surveillance, Memphis, Tennessee, USA
| | - Long V Nguyen
- Department of Animal Health, Ministry of Agriculture and Rural Development of Vietnam, Hanoi, Vietnam
| | - Ken Inui
- Food and Agriculture Organization of the United Nations, Hanoi, Vietnam
| | - Genyan Yang
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Adrian Creanga
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Li Wang
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Duong T Mai
- National Center for Veterinary Diagnostics, Department of Animal Health, Hanoi, Vietnam
| | - Sharmi Thor
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - James Stevens
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Thanh L To
- National Center for Veterinary Diagnostics, Department of Animal Health, Hanoi, Vietnam
| | - David E Wentworth
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Tung Nguyen
- Department of Animal Health, Ministry of Agriculture and Rural Development of Vietnam, Hanoi, Vietnam
| | - Dong V Pham
- Department of Animal Health, Ministry of Agriculture and Rural Development of Vietnam, Hanoi, Vietnam
| | - Juliet E Bryant
- Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Hanoi, Vietnam
- Center for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
| | - C Todd Davis
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| |
Collapse
|
215
|
Sparano JA, Gray R, Oktay MH, Entenberg D, Rohan T, Xue X, Donovan M, Peterson M, Shuber A, Hamilton D, D'Alfonso T, Goldstein LJ, Gerlter F, Davidson N, Condeelis J, Jones J. Abstract S4-04: Tumor microenvironment of metastasis (TMEM) score is associated with early distant recurrence in hormone receptor (HR) positive, HER2-negative early stage breast cancer (ESBC). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-s4-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Metastasis is the primary cause of death in ESBC. We have shown in mouse models that a subpopulation of tumor cells expressing invasive Mena isoforms stream, form microanatomic structures (“TMEM”) with endothelial cells and macrophages, intravasate into the circulation at TMEM sites, and metastasize (Harney et al. Cancer Discovery, 2015). Further, TMEM sites (“MetaSites”) are identifiable in human ESBC, and “MetaSite score” [MS] is positively associated with distant recurrence in HR+/HER2- ESBC independent of clinicopathologic features, including IHC4 (Rohan et al. JNCI 2014). Here we determined the association between MS and recurrence in an independent ESBC cohort (E2197; NCT00003519).
Methods: We evaluated primary tumors from 600 patients (median followup 14.8 years) with ESBC (weighted % = 50% T1, 54% N0, 46% N1) treated with surgery and 4 cycles of adjuvant chemotherapy (AC or AT) and endocrine therapy. Grade, ER, PR, and HER2, and Oncotype DX Recurrence Score (RS) were evaluated in central labs (Badve et al. JCO 2008), and MS was determined in a CLIA-certified lab using an analytically validated, fully automated digital pathology/image analysis method that identifies Mena expressing tumor cells in direct contact with CD68+ macrophages and CD31+ endothelial cells (ie, “TMEMs”, or “MetaSites”). The objectives were to determine the association between MS and distant relapse free interval (DRFI) and relapse free interval (RFI). Kaplan-Meier survival curves were used to estimate time-to-event distributions. Cox proportional hazards models were used to assess hazard ratio associated with MS while controlling for covariates, and allowing time-varying association with MS. Both Kaplan-Meier and Cox regression methods addressed stratified sampling by incorporating proper weights. All analyses were performed in R 3.2.3.
Results: MS ranged from 0-199; the weighted mean MS was lower in HR+/HER2- than TN (16.1 vs. 23.8, p=0.001) and HER2+ disease (26.2, p=0.003). MS was not associated with T or N status, and correlated poorly with RS (r=0.29). Proportional hazards models revealed a significant positive association between continuous MS and DRFI (p=0.001) and RFI (p=0.00006) in HR+/HER2- disease in years 0-5 (and by MS tertiles for DRFI [p=0.04] and RFI [p=0.01]), but not after year 5 or in TN or HER2+ disease. Proportional hazards models including clinical covariates (N0 vs. N1; T1 vs. T2; high vs. int. vs. low grade) also revealed significant positive associations for continuous MS with RFI (p=0.04), and borderline association with DRFI (p=0.08). Similar findings for MS (RFI p=0.05;DRFI p=0.10) were noted in a joint model including categorical RS (<18,18-30, >30).
Conclusions: MS, a novel metastasis biomarker reflecting interaction between streaming and metastasizing tumor cells and microenvironment, provides prognostic information complementary to classical clinicopathologic features and RS in HR+/HER2- ESBC. Further evaluation is warranted in order to identify patients at highest risk of recurrence within 5 years most likely to benefit from adjuvant chemotherapy or novel therapies. (Supported by BCRF and NCI CA21115, CA180794, CA23318, CA66636, CA180820).
Citation Format: Sparano JA, Gray R, Oktay MH, Entenberg D, Rohan T, Xue X, Donovan M, Peterson M, Shuber A, Hamilton D, D'Alfonso T, Goldstein LJ, Gerlter F, Davidson N, Condeelis J, Jones J. Tumor microenvironment of metastasis (TMEM) score is associated with early distant recurrence in hormone receptor (HR) positive, HER2-negative early stage breast cancer (ESBC) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr S4-04.
Collapse
Affiliation(s)
- JA Sparano
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - R Gray
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - MH Oktay
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - D Entenberg
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - T Rohan
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - X Xue
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - M Donovan
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - M Peterson
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - A Shuber
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - D Hamilton
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - T D'Alfonso
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - LJ Goldstein
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - F Gerlter
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - N Davidson
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - J Condeelis
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| | - J Jones
- Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; ECOG-ACRIN Research Group, Boston, MA; Albert Einstein College of Medicine, Bronx, NY; Mt. Sinai School of Medicine, New York, NY; MetaStat, Inc, Boston, MA; Weill Cornell Medical College, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; Massachusetts Institute of Technology, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| |
Collapse
|
216
|
O’Connell K, Williams L, Jones J, McCabe DJH, Murphy D, Killeen R, Tubridy N, O’Riordan S, McGuigan C. Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population. Ir J Med Sci 2017; 186:759-766. [DOI: 10.1007/s11845-016-1539-y] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Accepted: 12/24/2016] [Indexed: 01/23/2023]
|
217
|
Dessai SB, Chakraborty S, Babu T, Nayanar S, Bhattacharjee A, Jones J, Balasubramanian S, Patil VM. Tolerance of weekly paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin. Indian J Cancer 2017; 53:280-283. [PMID: 28071627 DOI: 10.4103/0019-509x.197742] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE There are little data regarding safety and effectiveness of neoadjuvant chemotherapy (NACT) in patients who are considered unfit for receiving 3 weekly paclitaxel and carboplatin. The aim of this study was to study the toxicity and response rates of weekly paclitaxel and carboplatin as NACT in such cohort of patients. METHODS Study population included advanced ovarian cancer patients who were unlikely to tolerate 3 weekly paclitaxel and carboplatin and hence received weekly paclitaxel (80 mg/m2) and carboplatin AUC-2 as NACT. The data regarding the baseline characteristics, chemotherapy tolerance, completion rates, toxicity (CTCAE version 4.02), and radiological response rates are presented. SPSS version 16 was used for analysis. Descriptive statistics is presented. RESULT Eleven patients received this schedule. Nine patients completed nine cycles of NACT. Except one, all patients completed NACT with an average relative dose intensity of >0.8. There was no chemotherapy-related mortality. Grade 3-4 life-threatening complications were seen in two patients. The post NACT response rate was 100%. CONCLUSION Weekly paclitaxel and carboplatin chemotherapy is safe and efficacious in patients who are unsuitable for 3 weekly paclitaxel and carboplatin chemotherapy schedules.
Collapse
Affiliation(s)
- S B Dessai
- Department of Surgical Oncology, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Chakraborty
- Department of Radiation Oncology, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - Tvs Babu
- Department of Cancer Imaging, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Nayanar
- Department of Oncopathology and Translational Medicine, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - A Bhattacharjee
- Department of Division of Clinical Research and Biostatistics, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - J Jones
- Department of Radiation Oncology, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Balasubramanian
- Department of Surgical Oncology, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - V M Patil
- Department of Clinical Hematology and Medical Oncology, Malabar Cancer Center, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| |
Collapse
|
218
|
Jones J, Taylor BS, Tieu HV, Wilkin TJ. CROI 2017: Advances in Antiretroviral Therapy. Top Antivir Med 2017; 25:51-67. [PMID: 28598790 PMCID: PMC5677043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The 2017 Conference on Retroviruses and Opportunistic Infections (CROI) featured exciting preclinical data on investigational antiretroviral agents with good in vitro efficacy and long half-lives. Investigational medications, including bictegravir, demonstrated excellent efficacy and tolerability, as did dual-agent therapy with dolutegravir paired with rilpivirine or with lamivudine. Dolutegravir monotherapy proved inadvisable due to virologic failure and resistance. The gap between high- and low-income settings along the HIV care continuum is narrowing, with Zimbabwe, Malawi, and Zambia approaching the 90-90-90 targets established by the joint United Nations Programme on HIV/AIDS (UNAIDS), whereas communities in the Southern United States are falling behind. Innovative strategies to improve outcomes include 2-way text messaging, home-based HIV testing, peer navigation, and New York City's realignment of services into comprehensive sexual health programs. A high prevalence of resistance was documented in low- and middle-income settings and policy considerations were modeled to address increasing resistance rates. Novel resistance mutations to integrase strand transfer inhibitors and nucleoside analogue reserve transcriptase inhibitors were identified, but the clinical implications are unclear and require further investigation. Several studies provided insights on dosing and safety of antiretroviral therapy to prevent mother-to-child transmission through pharmacokinetic analysis. A special session devoted to Zika virus included a study of its effects on the central nervous system and a promising animal study of a Zika vaccine.
Collapse
Affiliation(s)
- Joyce Jones
- Send correspondence to Joyce Jones, MD, 1800 Orleans Street, Carnegie 158, Baltimore, MD 21287, or
| | - Barbara S. Taylor
- Associate Professor of Infectious Diseases at the University of Texas Health Science Center at San Antonio
| | - Hong-Van Tieu
- Associate Member of the New York Blood Center and Assistant Professor of Clinical Medicine at Columbia University Medical Center in New York, New York
| | - Timothy J. Wilkin
- Associate Professor of Medicine at Weill Cornell Medicine in New York, New York
| |
Collapse
|
219
|
Hua D, Jiao Y, Neves R, Jones J. Periodic growth and growth cessations in the federally endangered freshwater mussel Cumberlandian combshell using a hierarchical Bayesian approach. ENDANGER SPECIES RES 2016. [DOI: 10.3354/esr00773] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
220
|
Bhal N, Davies J, Jones J, Morris R, Bhal P. The Outcome of an Office Based Surgical Treatment for Stress Urinary Incontinence Using an Adjustable Single Incision Sling. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
221
|
Sempos CT, Durazo-Arvizu RA, Binkley N, Jones J, Merkel JM, Carter GD. Developing vitamin D dietary guidelines and the lack of 25-hydroxyvitamin D assay standardization: The ever-present past. J Steroid Biochem Mol Biol 2016; 164:115-119. [PMID: 26321386 DOI: 10.1016/j.jsbmb.2015.08.027] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Revised: 08/20/2015] [Accepted: 08/24/2015] [Indexed: 01/13/2023]
Abstract
Unstandardized laboratory measurement of 25-hydroxyvitamin D (25(OH)D) confounds efforts to develop clinical and public health vitamin D guidelines. The Vitamin D Standardization Program (VDSP), an international collaborative effort, was founded in 2010 to correct this problem. Nearly all published vitamin D research is based on unstandardized laboratory 25(OH)D measurements. While it is impossible to standardize all old data, it may be possible to identify a small subset of prior studies critical to guidelines development. Once identified it may be possible to calibrate their 25(OH)D values to the NIST and Ghent University reference measurement procedures using VDSP methods thereby permitting future guidelines to be based on standardized results. We simulated the calibration of a small set of ten clinical trials of vitamin D supplementation on achieved 25(OH)D under minimal sun exposure. These studies were selected because they played a prominent role in setting the 2010 vitamin D dietary reference intakes (DRI). Using random-effects meta-regression analysis, Vitamin D External Quality Assessment (DEQAS) data on assay bias was used to simulate the potential bias due to the lack of assay standardization by calibrating the achieved 25(OH)D levels from those 10 studies to: (1) the largest negative, and (2) the largest positive bias from the DEQAS all laboratory trimmed mean (ALTM) for the appropriate assay and year of analysis. For a usual vitamin D intake of 600IU/day the difference in mean achieved 25(OH)D values for those two options was 20nmol/L. However, without re-calibration of 25(OH)D values it is impossible to know the degree to which any of the current guidelines may have been biased. This approach may help stimulate the search for and standardization of that small subset of key studies and, in the cases where standardization is impossible, to identify areas of urgently needed vitamin D research.
Collapse
Affiliation(s)
- C T Sempos
- Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892-7517, USA.
| | - R A Durazo-Arvizu
- Department of Public Health Sciences, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
| | - N Binkley
- Osteoporosis Clinical Research Program and Institute on Aging, University of Wisconsin-Madison, Madison, WI, USA
| | - J Jones
- Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK
| | - J M Merkel
- Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892-7517, USA
| | - G D Carter
- Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK
| |
Collapse
|
222
|
Wild C, Grössmann N, Bonanno P, Bucsics A, Furst J, Garuoliene K, Godman B, Gulbinovič J, Jones J, Pomorski M, Emprechtinger R. Utilisation of the ESMO-MCBS in practice of HTA. Ann Oncol 2016; 27:2134-2136. [DOI: 10.1093/annonc/mdw297] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
223
|
Oleolo M, Jones J, Goodson A, Kittur M. The mentor survey. Int J Surg 2016. [DOI: 10.1016/j.ijsu.2016.08.501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
224
|
Qureshi NR, Rintoul RC, Miles KA, George S, Harris S, Madden J, Cozens K, Little LA, Eichhorst K, Jones J, Moate P, McClement C, Pike L, Sinclair D, Wong WL, Shekhdar J, Eaton R, Shah A, Brindle L, Peebles C, Banerjee A, Dizdarevic S, Han S, Poon FW, Groves AM, Kurban L, Frew AJ, Callister ME, Crosbie P, Gleeson FV, Karunasaagarar K, Kankam O, Gilbert FJ. Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study. BMJ Open Respir Res 2016; 3:e000156. [PMID: 27843550 PMCID: PMC5073572 DOI: 10.1136/bmjresp-2016-000156] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2016] [Accepted: 08/17/2016] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION Solitary pulmonary nodules (SPNs) are common on CT. The most cost-effective investigation algorithm is still to be determined. Dynamic contrast-enhanced CT (DCE-CT) is an established diagnostic test not widely available in the UK currently. METHODS AND ANALYSIS The SPUtNIk study will assess the diagnostic accuracy, clinical utility and cost-effectiveness of DCE-CT, alongside the current CT and 18-flurodeoxyglucose-positron emission tomography) (18FDG-PET)-CT nodule characterisation strategies in the National Health Service (NHS). Image acquisition and data analysis for 18FDG-PET-CT and DCE-CT will follow a standardised protocol with central review of 10% to ensure quality assurance. Decision analytic modelling will assess the likely costs and health outcomes resulting from incorporation of DCE-CT into management strategies for patients with SPNs. ETHICS AND DISSEMINATION Approval has been granted by the South West Research Ethics Committee. Ethics reference number 12/SW/0206. The results of the trial will be presented at national and international meetings and published in an Health Technology Assessment (HTA) Monograph and in peer-reviewed journals. TRIAL REGISTRATION NUMBER ISRCTN30784948; Pre-results.
Collapse
Affiliation(s)
- N R Qureshi
- Department of Radiology , Papworth Hospital , Cambridge , UK
| | - R C Rintoul
- Department of Thoracic Oncology , Papworth Hospital , Cambridge , UK
| | - K A Miles
- Institute of Nuclear Medicine, University College London , London , UK
| | - S George
- Public Health Sciences and Medical Statistics, University of Southampton , Southampton , UK
| | - S Harris
- Public Health Sciences and Medical Statistics, University of Southampton , Southampton , UK
| | - J Madden
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - K Cozens
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - L A Little
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - K Eichhorst
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - J Jones
- Centre for Innovation and Leadership in Health Sciences, University of Southampton, UK
| | - P Moate
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - C McClement
- Southampton Clinical Trials Unit , University of Southampton , Southampton , UK
| | - L Pike
- Division of Imaging Sciences and Biomedical Engineering , King's College London , London , UK
| | - D Sinclair
- Division of Imaging Sciences and Biomedical Engineering , King's College London , London , UK
| | - W L Wong
- Department of Medical Physics , Paul Strickland Scanner Centre, Mount Vernon Hospital, East and North Herts NHS Trust , Stevenage , UK
| | - J Shekhdar
- Radiation Protection Department, East and North Hertfordshire NHS Trust, Stevenage, UK
| | - R Eaton
- Radiation Protection Department, East and North Hertfordshire NHS Trust, Stevenage, UK
| | - A Shah
- Radiation Protection Department, East and North Hertfordshire NHS Trust, Stevenage, UK
| | - L Brindle
- Faculty of Health Sciences , University of Southampton , Southampton , UK
| | - C Peebles
- Department of Radiology and Respiratory Medicine , Southampton University Hospitals NHS Foundation Trust , Southampton , UK
| | - A Banerjee
- Department of Radiology and Respiratory Medicine , Southampton University Hospitals NHS Foundation Trust , Southampton , UK
| | - S Dizdarevic
- Departments of Respiratory and Nuclear Medicine , Brighton and Sussex University Hospitals NHS Trust , Brighton , UK
| | - S Han
- West of Scotland PET Centre, Gartnavel Hospital , Glasgow , UK
| | - F W Poon
- West of Scotland PET Centre, Gartnavel Hospital , Glasgow , UK
| | - A M Groves
- Institute of Nuclear Medicine, University College London , London , UK
| | - L Kurban
- Department of Radiology , Aberdeen Royal Hospitals NHS Trust , Aberdeen , UK
| | - A J Frew
- Departments of Respiratory and Nuclear Medicine , Brighton and Sussex University Hospitals NHS Trust , Brighton , UK
| | - M E Callister
- Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - P Crosbie
- North West Lung Centre, University Hospital of South Manchester, Manchester, UK
| | - F V Gleeson
- Department of Radiology , Churchill Hospital and University of Oxford , Oxford , UK
| | - K Karunasaagarar
- Department of Radiology , Worcestershire Royal Hospital , Worcester , UK
| | - O Kankam
- Department of Thoracic Medicine , East Sussex Hospitals NHS Trust , Saint Leonards-on-Sea , UK
| | - F J Gilbert
- Department of Radiology , University of Cambridge School of Clinical Medicine, Biomedical research centre, University of Cambridge , Cambridge , UK
| |
Collapse
|
225
|
Zhang B, Jones J, Briggler A, Hubbard J, Kipp B, Sargent D, Dixon J, Grothey A. CDX2 loss as a prognostic and predictive biomarker in metastatic colorectal cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw370.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
226
|
Jones J, Rosaasen N, Taylor J, Mainra R, Shoker A, Blackburn D, Wilson J, Mansell H. Health Literacy, Knowledge, and Patient Satisfaction Before Kidney Transplantation. Transplant Proc 2016; 48:2608-2614. [DOI: 10.1016/j.transproceed.2016.07.018] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2016] [Accepted: 07/26/2016] [Indexed: 10/20/2022]
|
227
|
Theodorakopoulos C, Jones J, Bannerman E, Greig C. PT02.1: Do Different Obesity-Criteria Result in Different Phenotypes in Older People? Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30290-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
228
|
Adamcova K, Flachs P, Zouhar P, Bardova K, Svobodova M, Janovska P, Keenan A, Madsen L, Jones J, Kristiansen K, Kopecky J. Inducibility of triglyceride turnover in white fat – A marker of lean phenotype. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
229
|
Theodorakopoulos C, Bannerman E, Jones J, Greig C. SUN-P035: Screening for Sarcopenia and Sarcopenic Obesity in Scottish Community-Dwellers >65 Years. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30378-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
230
|
Jones J, Schweder P, Drummond KJ, Kaye AH. Use of tissue plasminogen activator in the treatment of shunt blockage secondary to intraventricular haemorrhage. J Clin Neurosci 2016; 34:281-282. [PMID: 27522496 DOI: 10.1016/j.jocn.2016.05.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2016] [Accepted: 05/16/2016] [Indexed: 10/21/2022]
Abstract
A 51-year-old woman with a history of idiopathic aqueduct stenosis, treated initially with insertion of a ventriculo peritoneal shunt, presented to our institution with shunt dysfunction. She had previously undergone multiple shunt revisions for shunt infection, shunt blockage and low-pressure symptoms, most recently with conversion to a ventriculo atrial (VA) shunt. Her VA shunt was again revised, with replacement of the ventricular catheter, however surgery was complicated by a large intraventricular haemorrhage (IVH) requiring placement of an external ventricular drain (EVD). Prior to eventual removal of her EVD it was determined that the VA shunt had blocked as a result of the IVH. Subsequently alteplase, a recombinant tissue plasminogen activator (tPA), was administered into the shunt reservoir, resulting in successful return of shunt function, therefore avoiding the need for further shunt revision. This is the first description of the use of tPA to unblock a shunt obstructed by blood.
Collapse
Affiliation(s)
- J Jones
- Department of Neurosurgery, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia.
| | - P Schweder
- Department of Neurosurgery, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia
| | - K J Drummond
- Department of Neurosurgery, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia; Department of Surgery, University of Melbourne, Royal Parade, Parkville, VIC 3010, Australia
| | - A H Kaye
- Department of Neurosurgery, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia; Department of Surgery, University of Melbourne, Royal Parade, Parkville, VIC 3010, Australia
| |
Collapse
|
231
|
Giuliani ME, Milne RA, Puts M, Sampson LR, Kwan JYY, Le LW, Alibhai SMH, Howell D, Abdelmutti N, Liu G, Papadakos J, Catton P, Jones J. The prevalence and nature of supportive care needs in lung cancer patients. ACTA ACUST UNITED AC 2016; 23:258-65. [PMID: 27536176 DOI: 10.3747/co.23.3012] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
PURPOSE In the present work, we set out to comprehensively describe the unmet supportive care and information needs of lung cancer patients. METHODS This cross-sectional study used the Supportive Care Needs Survey Short Form 34 (34 items) and an informational needs survey (8 items). Patients with primary lung cancer in any phase of survivorship were included. Demographic data and treatment details were collected from the medical charts of participants. The unmet needs were determined overall and by domain. Univariable and multivariable regression analyses were performed to determine factors associated with greater unmet needs. RESULTS From August 2013 to February 2014, 89 patients [44 (49%) men; median age: 71 years (range: 44-89 years)] were recruited. The mean number of unmet needs was 8 (range: 0-34), and 69 patients (78%) reported at least 1 unmet need. The need proportions by domain were 52% health system and information, 66% psychological, 58% physical, 24% patient care, and 20% sexuality. The top 2 unmet needs were "fears of the cancer spreading" [n = 44 of 84 (52%)] and "lack of energy/tiredness" [n = 42 of 88 (48%)]. On multivariable analysis, more advanced disease and higher MD Anderson Symptom Inventory scores were associated with increased unmet needs. Patients reported that the most desired information needs were those for information on managing symptoms such as fatigue (78%), shortness of breath (77%), and cough (63%). CONCLUSIONS Unmet supportive care needs are common in lung cancer patients, with some patients experiencing a very high number of unmet needs. Further work is needed to develop resources to address those needs.
Collapse
Affiliation(s)
- M E Giuliani
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - R A Milne
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - M Puts
- Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON
| | - L R Sampson
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - J Y Y Kwan
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - L W Le
- Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON
| | - S M H Alibhai
- Department of Medicine, University of Toronto, Toronto, ON
| | - D Howell
- Oncology Nursing Research, Princess Margaret Cancer Centre, Toronto, ON
| | - N Abdelmutti
- Health Promotion and Wellness, Princess Margaret Cancer Centre, Toronto, ON
| | - G Liu
- Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - J Papadakos
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - P Catton
- Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON
| | - J Jones
- Cancer Survivorship Program, Princess Margaret Cancer Centre, Toronto, ON
| |
Collapse
|
232
|
Macluskey M, Shepherd S, Carter E, Bulsara Y, Durham JA, Bell A, Dargue A, Emanuel C, Freeman C, Jones J, Khawaja N, Leeson R, Marley J, Andiappan M, Millsopp L, Nayyer N, Renton T, Taylor K, Thomson P, Toedtling V. A national follow-up survey of UK graduates opinion of undergraduate oral surgery teaching. Eur J Dent Educ 2016; 20:174-179. [PMID: 26121937 DOI: 10.1111/eje.12158] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 05/22/2015] [Indexed: 06/04/2023]
Abstract
INTRODUCTION A national follow-up survey was undertaken to determine whether dental graduates from 2009 perceived that their undergraduate oral surgery education had equipped them for general dental practice 4 years after graduating. MATERIALS AND METHODS Graduates from the same 13 United Kingdom dental schools who had taken part in the original survey were invited to take part in this follow-up online survey. Their contact details were identified via the general dental council register, social media and alumni groups. RESULTS In total, 161 responded (2009b) which represents 16% of the graduates of the original survey in 2009a. A similar percentage of these respondents perceived that the teaching in oral surgery had given them sufficient knowledge to undertake independent practice (83% and 79% in 2009a and 2009b, respectively). Most respondents (99% in both years) reported confidence in undertaking simple forceps exodontia. Confidence in surgical exodontia was poor in both surveys, but one area that appeared improved in the follow-up related to the sectioning of teeth (84% in 2009b compared with 49% in 2009a). Areas of weakness identified in 2009 were reported to be improved in the follow-up. CONCLUSION This follow-up survey supports the findings of the original survey. Future longitudinal studies would allow institutions to identify possible weaknesses in their curriculum and to track the career development of their graduates and facilitate robust data collection.
Collapse
MESH Headings
- Clinical Competence
- Competency-Based Education
- Curriculum
- Education, Dental/organization & administration
- Education, Dental/statistics & numerical data
- Education, Dental, Graduate/standards
- Education, Medical, Undergraduate/standards
- Female
- Follow-Up Studies
- General Practice, Dental
- Humans
- Male
- Schools, Dental
- Students, Dental/psychology
- Students, Dental/statistics & numerical data
- Surgery, Oral/education
- Teaching
- United Kingdom
Collapse
Affiliation(s)
- M Macluskey
- Unit of Oral Surgery and Medicine, Univeristy of Dundee, Dundee, UK
| | - S Shepherd
- Unit of Oral Surgery and Medicine, Univeristy of Dundee, Dundee, UK
| | - E Carter
- Oral Surgery, Barts and The London School of Medicine and Dentistry, London, UK
| | - Y Bulsara
- Oral Surgery, The School of Dentistry, Birmingham, UK
| | - J A Durham
- Oral and Maxillofacial Sciences, Newcastle University, Newcastle, UK
| | - A Bell
- Glasgow University, Glasgow, UK
| | - A Dargue
- Oral Surgery, School of Oral and Dental Sciences, Bristol, UK
| | - C Emanuel
- Oral Surgery, Cardiff University School of Dentistry, Cardiff, UK
| | - C Freeman
- Oral Surgery, University of Sheffield School of Dentistry, Sheffield, UK
| | - J Jones
- Department of Oral and Maxillofacial Surgery, Institute of Dentistry Barts and The London School of Medicine and Dentistry, London, UK
| | - N Khawaja
- Oral Surgery, Guys Kings and St Thomas' Dental Institute, London, UK
| | - R Leeson
- Oral Surgery, Eastman Dental Institute, London, UK
| | - J Marley
- Oral Surgery, Queens University of Belfast, Belfast, UK
| | - M Andiappan
- Dental Institute, King's College London, London, UK
| | - L Millsopp
- Oral Surgery, School of Dentistry, University of Liverpool, Liverpool, UK
| | - N Nayyer
- Unit of Oral Surgery and Medicine, Univeristy of Dundee, Dundee, UK
| | - T Renton
- Oral surgery, Kings College London Dental Institute, London, UK
| | - K Taylor
- Oral Surgery, School of Dentistry, University of Liverpool, Liverpool, UK
| | - P Thomson
- Oral and Maxillofacial Sciences, Newcastle University, Newcastle, UK
| | - V Toedtling
- Oral surgery, The School of Dentistry, The University of Manchester, Manchester, UK
| |
Collapse
|
233
|
Gunton J, Jones J, Nandal S, Alhammad N, Hartshorne T, Jones D, O'Shea C, Chew D, Marwick T, De Pasquale C. Evaluation of the “Door-Bell Test”, a Test of Frailty and HF Cardiorespiratory Status on Heart Failure Hospital Discharge, and its Relationship to Future Events. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
234
|
Yang G, Jones J, Jang Y, Davis CT. Multiplex assay for subtyping avian influenza A viruses by cDNA hybridization and adapter-mediated amplification. Appl Microbiol Biotechnol 2016; 100:8809-18. [DOI: 10.1007/s00253-016-7664-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 05/30/2016] [Accepted: 06/02/2016] [Indexed: 10/21/2022]
|
235
|
Dessai SB, Chakraborty S, Babu TVS, Nayanar S, Bhattacharjee A, Jones J, Balasubramanian S, Patil VM. Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin. South Asian J Cancer 2016; 5:63-6. [PMID: 27275450 PMCID: PMC4873699 DOI: 10.4103/2278-330x.181629] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
OBJECTIVE There are little data regarding safety and effectiveness of neoadjuvant chemotherapy (NACT) in patients who are considered unfit for receiving 3 weekly paclitaxel and carboplatin. The aim of this study was to examine the toxicity and response rates of weekly paclitaxel and carboplatin as NACT in such cohort of patients. METHODS Study population included advanced ovarian cancer patients who were unlikely to tolerate 3 weekly paclitaxel and carboplatin and hence received weekly paclitaxel (80 mg/m(2)) and carboplatin AUC-2 as NACT. The data regarding the baseline characteristics, chemotherapy tolerance, completion rates, toxicity (Common Terminology Criteria for Adverse Events version 4.02), and radiological response rates are presented. SPSS version 16 was used for analysis. Descriptive statistics is presented. RESULTS Eleven patients received this schedule. Nine patients completed nine cycles of NACT. Except one, all patients completed NACT with an average relative dose intensity of >0.8. There was no chemotherapy-related mortality. Grade 3-4 life-threatening complications were seen in two patients. The post NACT response rate was 100%. CONCLUSIONS Weekly paclitaxel and carboplatin chemotherapy is safe and efficacious in patients who are unsuitable for 3 weekly paclitaxel and carboplatin chemotherapy schedules.
Collapse
Affiliation(s)
- S B Dessai
- Department of Surgical Oncology, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Chakraborty
- Department of Radiation Oncology, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - T V S Babu
- Department of Cancer Imaging, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Nayanar
- Department of Oncopathology and Translational Medicine, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - A Bhattacharjee
- Division of Clinical Research and Biostatistics, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - J Jones
- Department of Radiation Oncology, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - S Balasubramanian
- Department of Surgical Oncology, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| | - Vijay M Patil
- Clinical Hematology and Medical Oncology, Malabar Cancer Center, Moozhikkara, Kodiyeri, Thalassery, Kannur, Kerala, India
| |
Collapse
|
236
|
Jones J, Flaherty G, Gibson I, Walsh A, Kerins C, Costello C, Connolly S, Wood D. PT037 Health Economic Evaluation of a Preventive Cardiology Programme in Ireland. Glob Heart 2016. [DOI: 10.1016/j.gheart.2016.03.453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
237
|
Jones J, McBain H, Lamontagne-Godwin F, Mulligan K, Haddad M, Flood C, Thomas D, Simpson A. Severe mental illness and type 2 diabetes: using theory and research evidence to develop complex behaviour change interventions. J Psychiatr Ment Health Nurs 2016; 23:312-21. [PMID: 27307262 DOI: 10.1111/jpm.12311] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/19/2016] [Indexed: 01/20/2023]
Affiliation(s)
- J Jones
- Centre for Mental Health Research, School of Health Sciences, City University London, UK
| | - H McBain
- Centre for Health Services Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - F Lamontagne-Godwin
- Centre for Mental Health Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - K Mulligan
- Centre for Health Services Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - M Haddad
- Centre for Mental Health Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - C Flood
- Centre for Mental Health Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - D Thomas
- Centre for Mental Health Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| | - A Simpson
- Centre for Mental Health Research, School of Health Sciences, City University London, UK.,East London NHS Foundation Trust, London, UK
| |
Collapse
|
238
|
Keeley T, Williamson P, Callery P, Jones LL, Mathers J, Jones J, Young B, Calvert M. The use of qualitative methods to inform Delphi surveys in core outcome set development. Trials 2016; 17:230. [PMID: 27142835 PMCID: PMC4855446 DOI: 10.1186/s13063-016-1356-7] [Citation(s) in RCA: 102] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2015] [Accepted: 04/22/2016] [Indexed: 11/12/2022] Open
Abstract
Background Core outcome sets (COS) help to minimise bias in trials and facilitate evidence synthesis. Delphi surveys are increasingly being used as part of a wider process to reach consensus about what outcomes should be included in a COS. Qualitative research can be used to inform the development of Delphi surveys. This is an advance in the field of COS development and one which is potentially valuable; however, little guidance exists for COS developers on how best to use qualitative methods and what the challenges are. This paper aims to provide early guidance on the potential role and contribution of qualitative research in this area. We hope the ideas we present will be challenged, critiqued and built upon by others exploring the role of qualitative research in COS development. This paper draws upon the experiences of using qualitative methods in the pre-Delphi stage of the development of three different COS. Using these studies as examples, we identify some of the ways that qualitative research might contribute to COS development, the challenges in using such methods and areas where future research is required. Results Qualitative research can help to identify what outcomes are important to stakeholders; facilitate understanding of why some outcomes may be more important than others, determine the scope of outcomes; identify appropriate language for use in the Delphi survey and inform comparisons between stakeholder data and other sources, such as systematic reviews. Developers need to consider a number of methodological points when using qualitative research: specifically, which stakeholders to involve, how to sample participants, which data collection methods are most appropriate, how to consider outcomes with stakeholders and how to analyse these data. A number of areas for future research are identified. Conclusions Qualitative research has the potential to increase the research community’s confidence in COS, although this will be dependent upon using rigorous and appropriate methodology. We have begun to identify some issues for COS developers to consider in using qualitative methods to inform the development of Delphi surveys in this article.
Collapse
Affiliation(s)
- T Keeley
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, England.
| | - P Williamson
- Department of Biostatistics, MRC North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, England
| | - P Callery
- Midwifery and Social Work, School of Nursing, University of Manchester, Manchester, England
| | - L L Jones
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, England
| | - J Mathers
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, England
| | - J Jones
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, England
| | - B Young
- Department of Psychological Sciences and MRC North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, England
| | - M Calvert
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, England
| |
Collapse
|
239
|
Finch M, Jones J, Yoong S, Wiggers J, Wolfenden L. Effectiveness of centre-based childcare interventions in increasing child physical activity: a systematic review and meta-analysis for policymakers and practitioners. Obes Rev 2016; 17:412-28. [PMID: 27005942 DOI: 10.1111/obr.12392] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2015] [Revised: 01/27/2016] [Accepted: 01/28/2016] [Indexed: 11/29/2022]
Abstract
CONTEXT The review describes the effectiveness of physical activity interventions implemented in centre-based childcare services and (i) examines characteristics of interventions that may influence intervention effects; (ii) describes the effects of pragmatic interventions and non-pragmatic interventions; (iii) assesses adverse effects; and (iv) describes cost-effectiveness of interventions METHODS Data sources were Cochrane Central Register of Controlled trials, MEDLINE, EMBASE, PsycINFO, ERIC, CINAHL, SCOPUS and SPORTDISCUS. Studies selected included randomized controlled trials conducted in centre-based childcare including an intervention to increase objectively measured physical activity in children aged less than 6 years. Data were converted into standardized mean difference (SMD) and analysed using a random effects model. RESULTS Overall interventions significantly improved child physical activity (SMD 0.44; 95% confidence interval [CI]: 0.12-0.76). Significant effects were found for interventions that included structured activity (SMD 0.53; 95% CI: 0.12-0.94), delivery by experts (SMD 1.26; 95% CI: 0.20-2.32) and used theory (SMD 0.76; 95% CI: 0.08-1.44). Non-pragmatic (SMD 0.80; 95% CI: 0.12-1.48) but not pragmatic interventions (SMD 0.10; 95% CI:-0.13-0.33) improved child physical activity. One trial reported adverse events, and no trials reported cost data. CONCLUSIONS Intervention effectiveness varied according to intervention and trial design characteristics. Pragmatic trials were not effective, and information on cost and adverse effects was lacking. Evidence gaps remain for policymakers and practitioners regarding the effectiveness and feasibility of childcare-based physical activity interventions.
Collapse
Affiliation(s)
- M Finch
- Hunter New England Population Health, Wallsend, NSW, Australia.,School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia
| | - J Jones
- School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia
| | - S Yoong
- School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia
| | - J Wiggers
- Hunter New England Population Health, Wallsend, NSW, Australia.,School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.,Hunter Medical Research Institute, New Lambton Heights, NSW, Australia
| | - L Wolfenden
- Hunter New England Population Health, Wallsend, NSW, Australia.,School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.,Hunter Medical Research Institute, New Lambton Heights, NSW, Australia
| |
Collapse
|
240
|
Ricketts K, Navarro C, Lane K, Moran M, Blowfield C, Kaur U, Cotten G, Tomala D, Lord C, Jones J, Adeyemi A. Implementation and evaluation of a transit dosimetry system for treatment verification. Phys Med 2016; 32:671-80. [PMID: 27134042 DOI: 10.1016/j.ejmp.2016.04.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2015] [Revised: 04/20/2016] [Accepted: 04/21/2016] [Indexed: 10/21/2022] Open
Abstract
PURPOSE To evaluate a formalism for transit dosimetry using a phantom study and prospectively evaluate the protocol on a patient population undergoing 3D conformal radiotherapy. METHODS Amorphous silicon EPIDs were calibrated for dose and used to acquire images of delivered fields. The measured EPID dose map was back-projected using the planning CT images to calculate dose at pre-specified points within the patient using commercially available software, EPIgray (DOSIsoft, France). This software compared computed back-projected dose with treatment planning system dose. A series of tests were performed on solid water phantoms (linearity, field size effects, off-axis effects). 37 patients were enrolled in the prospective study. RESULTS The EPID dose response was stable and linear with dose. For all tested field sizes the agreement was good between EPID-derived and treatment planning system dose in the central axis, with performance stability up to a measured depth of 18cm (agreement within -0.5% at 10cm depth on the central axis and within -1.4% at 2cm off-axis). 126 transit images were analysed of 37 3D-conformal patients. Patient results demonstrated the potential of EPIgray with 91% of all delivered fields achieved the initial set tolerance level of ΔD of 0±5-cGy or %ΔD of 0±5%. CONCLUSIONS The in vivo dose verification method was simple to implement, with very few commissioning measurements needed. The system required no extra dose to the patient, and importantly was able to detect patient position errors that impacted on dose delivery in two of cases.
Collapse
Affiliation(s)
- K Ricketts
- Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK.
| | - C Navarro
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - K Lane
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - M Moran
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - C Blowfield
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - U Kaur
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - G Cotten
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - D Tomala
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - C Lord
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - J Jones
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| | - A Adeyemi
- Department of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust, Reading, UK
| |
Collapse
|
241
|
Patil VM, Muttath G, Babu S, Kumar ST, Jones J, Sen S, Chakraborty S. Does the use of induction chemotherapy in oral cavity cancer compromise subsequent loco-regional treatment delivery: Results from a matched pair analysis. Indian J Cancer 2016; 52:632-6. [PMID: 26960501 DOI: 10.4103/0019-509x.178442] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Neoadjuvant chemotherapy is being increasingly used in patients with unresectable oral cavity cancers to make them resectable. However, its impact on locoregional treatment delivery in such setting remains poorly studied. AIMS To evaluate the impact of neoadjuvant chemotherapy on delivery of further locoregional treatment. SETTINGS AND DESIGN Mono institutional retrospective audit of patients with oral cavity squamous cell cancers treated with neoadjuvant triplet chemotherapy in India. MATERIALS AND METHODS Patients receiving neoadjuvant chemotherapy (n = 14) from May 2012 to April 2014 were matched 1:2 to patients undergoing upfront surgery (n = 28) based on age (>60 or 60 and less), gender (male or female) and subsite site (tongue and floor of mouth or buccoalveolar complex). Data regarding factors related to the delivery of locoregional treatment and toxicities were compiled. STATISTICAL ANALYSIS Descriptive analysis in the form of median (range) for continuous variables and frequencies for categorical variables. RESULTS Patients undergoing neoadjuvant chemotherapy required more extensive resections and had greater operative time (460 vs. 415 min, P < 0.001). A greater incidence of locoregional wound complications was seen as a consequence (57.1% vs. 14.3%, P, 0.01). However, toxicities during radiotherapy were not substantially different between the two groups and compliance to radiation was also similar. Total package time of 100 days or less, was maintained in 90% of patients in both groups. CONCLUSIONS Delivery of neoadjuvant chemotherapy does not impair the ability to deliver locoregional treatment.
Collapse
Affiliation(s)
| | | | | | | | | | | | - S Chakraborty
- Department of Radiation Oncology, Malabar Cancer Centre, Thalassery, Kerala, India
| |
Collapse
|
242
|
Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study. Am J Transplant 2016; 16:869-76. [PMID: 26845630 DOI: 10.1111/ajt.13591] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Revised: 09/11/2015] [Accepted: 09/23/2015] [Indexed: 01/25/2023]
Abstract
Some living kidney donors (LKDs) incur costs associated with donation, although these costs are not well characterized in the United States. We collected cost data in the 12 mo following donation from 182 LKDs participating in the multicenter prospective Kidney Donor Outcomes Cohort (KDOC) Study. Most LKDs (n = 167, 92%) had one direct cost or more following donation, including ground transportation (86%), health care (41%), meals (53%), medications (36%), lodging (23%), and air transportation (12%). LKDs missed 33 072 total work hours, 40% of which were unpaid and led to $302 175 in lost wages (mean $1660). Caregivers lost $68 655 in wages (mean $377). Although some donors received financial assistance, 89% had a net financial loss in the 12-mo period, with one-third (33%) reporting a loss exceeding $2500. Financial burden was higher for those with greater travel distance to the transplant center (Spearman's ρ = 0.26, p < 0.001), lower household income (Spearman's ρ = -0.25, p < 0.001), and more unpaid work hours missed (Spearman's ρ = 0.52, p < 0.001). Achieving financial neutrality for LKDs must be an immediate priority for the transplant community, governmental agencies, insurance companies, nonprofit organizations, and society at large.
Collapse
Affiliation(s)
- J R Rodrigue
- Center for Transplant Outcomes and Quality Improvement, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.,Harvard Medical School, Boston, MA
| | - J D Schold
- Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
| | - P Morrissey
- Transplant Center, Rhode Island Hospital, Providence, RI
| | - J Whiting
- Maine Transplant Center, Maine Medical Center, Portland, ME
| | - J Vella
- Maine Transplant Center, Maine Medical Center, Portland, ME
| | - L K Kayler
- Montefiore Einstein Center for Transplantation, Bronx, NY.,Regional Center of Excellence for Transplantation and Kidney Care, Erie County Medical Center, University of Buffalo, Buffalo, NY
| | - D Katz
- Organ Transplantation Program, University of Iowa Hospitals and Clinics, Iowa City, IA
| | - J Jones
- Organ Transplantation Program, University of Iowa Hospitals and Clinics, Iowa City, IA
| | - B Kaplan
- Department of Medicine, University of Arizona, Tucson, AZ.,School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ
| | - A Fleishman
- Center for Transplant Outcomes and Quality Improvement, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA
| | - M Pavlakis
- Center for Transplant Outcomes and Quality Improvement, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.,Harvard Medical School, Boston, MA
| | - D A Mandelbrot
- Center for Transplant Outcomes and Quality Improvement, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.,Department of Medicine, University of Wisconsin, Madison, WI
| | | |
Collapse
|
243
|
Boughey JC, Kalari KR, Suman VJ, McLaughlin SA, Moreno Aspitia A, Moyer AM, Northfelt DW, Gray RJ, Vedell PT, Tang X, Dockter TJ, Jones KN, Felten SJ, Conners AL, Hart SN, Visscher DW, Wieben ED, Ingle JN, Hartman AR, Timms K, Elkin E, Jones J, Wang L, Weinshilboum RW, Goetz MP. Abstract P3-07-29: Role of germline BRCA status and tumor homologous recombination (HR) deficiency in response to neoadjuvant weekly paclitaxel followed by anthracycline-based chemotherapy. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Both HR deficiency and BRCA mutation status predict response to platinum-based therapy and BRCA mutation status predicts docetaxel resistance. However, the association of either biomarker with response to the individual elements of either AC or taxanes (T) is unknown since T is commonly given concomitantly with or after anthracyclines (A). We evaluated the association of HRD and BRCA mutation status with response to neoadjuvant weekly T followed by AC or (F)EC in high-risk breast cancer.
Methods: We studied 140 high risk Stage I-III breast cancer patients (pts), enrolled in the breast cancer genome guided therapy study (BEAUTY), obtaining biopsies for DNA/RNA sequencing and MRI imaging to assess response to neoadjuvant weekly T (+trastuzumab+/-pertuzumab for HER2+ disease) followed by AC or (F)EC. Germline BRCA status and HR status of tumor samples (Myriad laboratories) were obtained. HR deficient tumor was defined as HRD score ≥42 or BRCA mutation. MRI response by changes in tumor size after 12 weeks of T was classified by WHO criteria. pCR was defined as ypT0/Tis ypN0. Both MRI response after T and pCR (after T and AC) were examined in terms of germline BRCA mutation (gBRCAmut vs. gBRCAwt) and tumor HR deficiency.
Results: Of 140 pts enrolled, 8 withdrew consent and 2 carboplatin treated pts were excluded. Germline data were available for 124/130 pts. 12 patients had BRCA deleterious germline mutations (4 BRCA1, 8 BRCA2). MRI partial (PR)/complete response (CR) rate to T was 47.3% (95% CI: 37.8-57.0%) in the BRCAwt group and 66.7% (95% CI: 34.9-90.1%) in the BRCAmut group. No MRI CR's were observed in BRCA1 mut pts. In contrast, pCR rate was 50% in the 12 gBRCAmut pts (95% CI: 21.1-78.9%) and 31.3% in the 112 gBRCAwt pts (95% CI: 22.8-40.7%). HR deficiency status has thus far been determined for 74 pts: 26 pts have HD deficient tumors: 18 TNBC, 5 Luminal B, 2 ER-/HER2+; and 1 ER+/HER2+. Determination of HR deficiency is ongoing and will be reported for the full cohort in terms of 12 week MRI response to T and pCR to T+AC.
HR deficientMolecular Subtypeyes (%)no (%)TBD (%)Luminal A0/112/11 (18.2)9/11 (81.8)Luminal B5/37 (13.5)13/37 (35.1)19/37 (51.3)Luminal NOS0/21/2 (50)1/2 (50)ER+/Her2+1/17 (5.8)14/17 (82.4)2/17 (11.8)ER-/Her2+2/20 (10)11/20 (55)7/20 (35)Triple Negative18/43 (41.9)6/43 (18.6)17/43 (39.5)germline BRCA statusMRI partial response after T (%)MRI complete response after T (%)pCR after T&AC (%)BRCA11/4 (25)0/42/4 (50)BRCA25/8 (62.5)2/8 (25)4/8 (50)BRCAwt35/112 (31.3)18/112 (16.1)35/112 (31.3)
Conclusion: In the setting of neoadjuvant weekly T followed by AC, pCR rates were non-significantly higher in pts with BRCA1 mutations. While we observed no overall association between BRCA mutation status and response rates to taxanes; nearly all MRI responses to taxanes (partial and complete) were observed in the BRCA2 group. Prospective studies are needed to validate these findings and to determine whether BRCA status can be used to select therapy. HR deficiency is uncommon in luminal A and HER2+, frequent in TNBC, and the association of HRD with both MRI response to taxanes and pCR will be reported at the meeting.
Citation Format: Boughey JC, Kalari KR, Suman VJ, McLaughlin SA, Moreno Aspitia A, Moyer AM, Northfelt DW, Gray RJ, Vedell PT, Tang X, Dockter TJ, Jones KN, Felten SJ, Conners AL, Hart SN, Visscher DW, Wieben ED, Ingle JN, Hartman A-R, Timms K, Elkin E, Jones J, Wang L, Weinshilboum RW, Goetz MP. Role of germline BRCA status and tumor homologous recombination (HR) deficiency in response to neoadjuvant weekly paclitaxel followed by anthracycline-based chemotherapy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-29.
Collapse
Affiliation(s)
- JC Boughey
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - KR Kalari
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - VJ Suman
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - SA McLaughlin
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - A Moreno Aspitia
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - AM Moyer
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - DW Northfelt
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - RJ Gray
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - PT Vedell
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - X Tang
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - TJ Dockter
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - KN Jones
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - SJ Felten
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - AL Conners
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - SN Hart
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - DW Visscher
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - ED Wieben
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - JN Ingle
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - A-R Hartman
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - K Timms
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - E Elkin
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - J Jones
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - L Wang
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - RW Weinshilboum
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| | - MP Goetz
- Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AR; Mayo Clinic, Jacksonville, FL; Myriad Genetic Laboratories, Salt Lake City, UT
| |
Collapse
|
244
|
Jones J, Waldron J, Extence H, Drake D. Outcome of palate re-repair for Velopharyngeal Dysfunction in the cleft palate patient. Br J Oral Maxillofac Surg 2015. [DOI: 10.1016/j.bjoms.2015.08.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
245
|
Wong H, Eso K, Ip A, Jones J, Kwon Y, Powelson S, de Grood J, Geransar R, Santana M, Joffe AM, Taylor G, Missaghi B, Pearce C, Ghali W, Conly J. Use of ward closure to control outbreaks among hospitalized patients in acute care settings: a systematic review. Antimicrob Resist Infect Control 2015. [PMCID: PMC4474650 DOI: 10.1186/2047-2994-4-s1-o53] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
246
|
Jansoniene O, Jones J, Tsoutsouras T, Hall D. Tracheostomy practice overview in cardiothoracic intensive care unit. Intensive Care Med Exp 2015. [PMCID: PMC4796611 DOI: 10.1186/2197-425x-3-s1-a743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
|
247
|
Hughes K, Lewis S, Katz L, Jones J. 146 Safety of Computer Interpretation of Normal Triage Electrocardiograms. Ann Emerg Med 2015. [DOI: 10.1016/j.annemergmed.2015.07.178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
248
|
Ofstad T, Bannerman E, Davidson H, Jones J. An investigation into food and fluid provision and consumption in a Scottish rehabilitation hospital for older adults. Clin Nutr ESPEN 2015; 10:e183-e184. [DOI: 10.1016/j.clnesp.2015.03.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
249
|
Sharp A, Gould M, Jones J, Wu I, Huynh D, Kocher K, Shah N. 37 Emergency Department Hospitalization Practices for Community-Acquired Pneumonia Encounters: Validating CURB-65 for Discharged Patients. Ann Emerg Med 2015. [DOI: 10.1016/j.annemergmed.2015.07.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
250
|
Drinkwater B, Clarke B, Ratcliffe J, Jones J, Deel-Smith P, Cooper S. Home parenteral nutrition use in palliative care: A retrospective study to identify potential prognostic indicators. Clin Nutr ESPEN 2015; 10:e180-e181. [DOI: 10.1016/j.clnesp.2015.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|